Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line
Affiliations
- PMID: 9014013
Item in Clipboard
Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line
Acta Virol.
1996 Sep.
Abstract
Biological activities of human interferon (IFN) omega are less well characterized than those of other type I human IFNs. We compared the ability of recombinant IFN-omega, IFN-alpha 2 and IFN-gamma to inhibit the production of viral hepatitis B surface antigen (HBsAg) in the human hepatoma cell line PLC/PRF/5. The results demonstrated that the capacity of IFN-omega to suppress the HBsAg synthesis was similar to that of IFN-alpha 2. The kinetics of the inhibitory effect of IFN-gamma differed from those of the two other IFNs.
Similar articles
-
Effect of human leukocyte interferon on HBsAg production in PLC/PRF/5 human hepatoma cell line.Acta Virol. 1987 Sep;31(5):404-9. Acta Virol. 1987. PMID: 2891279
-
Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.Arzneimittelforschung. 1998 Mar;48(3):343-7. Arzneimittelforschung. 1998. PMID: 9553691
-
Relationship between depression of HBsAg production and DNA synthesis by interferons in human hepatoma cell line.Acta Virol. 1990 Feb;34(1):44-8. Acta Virol. 1990. PMID: 1975724
-
Human interferon omega--a review.Mult Scler. 1995;1 Suppl 1:S44-7. Mult Scler. 1995. PMID: 9345398 Review.
-
Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection.Cell Physiol Biochem. 2018;51(5):2377-2396. doi: 10.1159/000495897. Epub 2018 Dec 11. Cell Physiol Biochem. 2018. PMID: 30537741 Review.
Cited by
-
Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B.World J Gastroenterol. 2021 Apr 14;27(14):1369-1391. doi: 10.3748/wjg.v27.i14.1369. World J Gastroenterol. 2021. PMID: 33911462 Free PMC article. Review.